Relmada Therapeutics, Inc. (RLMD)
3.94
+0.20
(+5.35%)
USD |
NASDAQ |
Jan 20, 16:00
3.94
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics Price: 3.94 for Jan. 20, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amicus Therapeutics, Inc. | 14.31 |
| Invivyd, Inc. | 2.24 |
| Arcellx, Inc. | 72.17 |
| Puma Biotechnology, Inc. | 6.60 |
| NovaBay Pharmaceuticals, Inc. | 6.50 |
Price Related Metrics
| Price to Book Value | 30.52 |
| Earnings Yield | -45.61% |
| Market Cap | 288.93M |